Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04205630 |
| Consolidated Lead Sponsor | Byondis |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 64 participants (ACTUAL) |
| Registered Start Date | 2020-05-28 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Yale Cancer Center and Smilow Cancer Hospital | New Haven, CT | Open Hospital Dossier -> |
| National Cancer Centre Singapore | Singapore, Singapore | Open Hospital Dossier -> |
| Seoul National University Bundang Hospital | Seongnam-si, South Korea | Open Hospital Dossier -> |
| Seoul National University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.